GSK plc Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | $0.73 | $0.73 | $0.73 |
Q2 2024 | 1 | $0.77 | $0.77 | $0.77 |
Q3 2024 | 1 | $0.84 | $0.88 | $0.86 |
Q4 2024 | 3 | $0.32 | $0.49 | $0.43 |
Q1 2025 | 1 | $0.93 | $0.95 | $0.94 |
Q2 2025 | 1 | $0.94 | $0.96 | $0.95 |
Q3 2025 | 1 | $1.00 | $1.02 | $1.01 |
Q4 2025 | 1 | $0.62 | $0.63 | $0.62 |
GSK plc Earnings Date And Information
GSK plc last posted its earnings results on Wednesday, October 30th, 2024. The company reported $1.27 earnings per share for the quarter, topping analysts' consensus estimates of $1.16 by $0.11. The company had revenue of 8.01 B for the quarter and had revenue of 30.33 B for the year. GSK plc has generated $2 earnings per share over the last year ($2.4 diluted earnings per share) and currently has a price-to-earnings ratio of 22.98. GSK plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based on prior year's report dates.
GSK plc Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
07/31/2024 | Q3 2024 | $1.00 | -$0.03 | -1.03 | $10.52 B | $8.01 B |
05/01/2024 | Q2 2024 | $0.94 | $0.58 | -0.36 | $9.57 B | $7.88 B |
05/01/2024 | Q1 2024 | $0.94 | $0.51 | -0.43 | $7.36 B | |
11/01/2023 | Q4 2023 | $1.09 | $0.17 | -0.92 | $8.05 B | |
11/01/2023 | Q3 2023 | $1.09 | $0.72 | -0.37 | $9.37 B | $8.15 B |
07/26/2023 | Q2 2023 | $0.87 | $0.80 | -0.07 | $8.78 B | $7.18 B |
02/01/2023 | Q1 2023 | $0.50 | $0.74 | 0.24 | $6.95 B | |
11/02/2022 | Q4 2022 | $0.90 | $0.72 | -0.18 | $7.38 B | |
11/02/2022 | Q3 2022 | $0.90 | $5.37 | 4.47 | $8.31 B | $7.83 B |
04/27/2022 | Q2 2022 | $0.93 | $0.42 | -0.51 | $7.88 B | $6.93 B |
02/09/2022 | Q1 2022 | $0.79 | $0.90 | 0.11 | $9.78 B | |
10/27/2021 | Q4 2021 | $1.00 | $0.37 | -0.63 | $9.53 B | |
07/28/2021 | Q3 2021 | $0.68 | $0.68 | 0 | $11.90 B | $9.08 B |
04/28/2021 | Q2 2021 | $0.79 | $0.70 | -0.09 | $10.45 B | $8.09 B |
02/03/2021 | Q1 2021 | $0.88 | $0.54 | -0.34 | $7.42 B | |
10/28/2020 | Q4 2020 | $0.98 | $0.34 | -0.64 | $8.74 B | |
07/29/2020 | Q3 2020 | $0.61 | $0.62 | 0.01 | $11.45 B | $8.65 B |
04/29/2020 | Q2 2020 | $0.99 | $1.14 | 0.15 | $9.71 B | $7.62 B |
02/05/2020 | Q1 2020 | $0.84 | $0.79 | -0.05 | $9.09 B | |
10/30/2019 | Q4 2019 | $1.04 | $0.66 | -0.38 | $8.90 B |
GSK plc Earnings: Frequently Asked Questions
-
When is GSK plc's earnings date?
GSK plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based off last year's report dates.
-
Did GSK plc beat their earnings estimates last quarter?
In the previous quarter, GSK plc (:GSK) reported $1.27 earnings per share (EPS) to beat the analysts' consensus estimate of $1.16 by $0.11.
-
How can I listen to GSK plc's earnings conference call?
The conference call for GSK plc's latest earnings report can be listened to online.
-
How can I read GSK plc's conference call transcript?
The conference call transcript for GSK plc's latest earnings report can be read online.
-
How much revenue does GSK plc generate each year?
GSK plc (:GSK) has a recorded annual revenue of $30.33 B.
-
How much profit does GSK plc generate each year?
GSK plc (:GSK) has a recorded net income of $30.33 B. GSK plc has generated $2.43 earnings per share over the last four quarters.
-
What is GSK plc's price-to-earnings ratio?
GSK plc (:GSK) has a price-to-earnings ratio of 22.98 and price/earnings-to-growth ratio is -0.64.